GDOC – Goldman Sachs ETF Trust
Goldman Sachs ETF Trust (GDOC) is a Health ETF, issued by Goldman Sachs, $21.5M in assets, 0.75% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.0%, 1 year +8.7%.
Invests in U.S. and non-U.S. healthcare companies aligned with key innovation themes like genomics and digital healthcare.
Top holdings
- LLY – Eli Lilly and Company, 11.9%
- JNJ – Johnson & Johnson, 6.6%
- BSX – Boston Scientific Corp, 6.4%
- TMO – Thermo Fisher Scientific Inc, 5.9%
- AZN – AstraZeneca PLC, 5.5%
- ISRG – Intuitive Surgical Inc, 4.6%
- ABT – Abbott Laboratories, 4.4%
- GH – Guardant Health Inc, 3.8%
- ARGX – argenx NV ADR, 3.7%
- COR – Cencora Inc., 3.2%
- A – Agilent Technologies Inc, 3.2%
- 7741 – Hoya Cor, 3.2%
- LONN – Lonza Group AG, 2.9%
- DXCM – DexCom Inc, 2.5%
- PODD – Insulet Corporation, 2.1%
- MTD – Mettler-Toledo International Inc, 1.8%
- VEEV – Veeva Systems Inc Class A, 1.8%
- ROIV – Roivant Sciences Ltd, 1.8%
- DIM – Sartorius Stedim Biotech SA, 1.8%
- DHR – Danaher Corporation, 1.8%
- MDGL – Madrigal Pharmaceuticals Inc, 1.6%
- RGEN – Repligen Corporation, 1.5%
- APGE – Apogee Therapeutics, Inc. Common Stock, 1.4%
- RVMD – Revolution Medicines Inc, 1.4%
- INSM – Insmed Inc, 1.3%